Overview
Pralay Maiti practices practicing medicine in Varanasi, India.
Their clinical expertise encompasses Melanoma, Secondary Parkinsonism, Neurotoxicity Syndromes, and Necrosis.
They are actively involved in clinical research, co-authoring 80 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pralay Maiti
Is Pralay Maiti a top-rated expert for Melanoma?
MediFind is an objective health platform that identifies experts based on real-world data. Pralay Maiti is classified as an Experienced expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pralay Maiti participate in research or clinical trials?
Yes. Pralay Maiti has published 80 articles and abstracts on conditions like Melanoma. You can view a list of Pralay Maiti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- MelanomaMaiti isExperienced. Learn about Melanoma.
- NecrosisMaiti isExperienced. Learn about Necrosis.
- Neuroendocrine TumorMaiti isExperienced. Learn about Neuroendocrine Tumor.
- Neurotoxicity SyndromesMaiti isExperienced. Learn about Neurotoxicity Syndromes.
- Secondary ParkinsonismMaiti isExperienced. Learn about Secondary Parkinsonism.